You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國光大水務(01857.HK)取得濟南醫學中心項目一期 投資約3.2億元
格隆匯 01-03 08:26

格隆匯1月3日丨中國光大水務(01857.HK)發佈公吿,2022年1月3日,光大水務宣佈日前取得濟南國際醫學科學中心污水處理項目(“濟南醫學中心項目”)一期,投資約人民幣3.20億元。

根據披露,濟南醫學中心項目一期將以建設-運營-移交(BOT)模式投資、建設和運營,特許經營期30年(含建設期),特許經營區域將包含濟南國際醫學科學中心區域內的太平河片區、美里片區及峨眉片區。該項目將採用全地下式結構建設,為特許經營區域提供市政污水處理服務,設計污水處理規模50,000立方米/日,出水水質將執行《城鎮污水處理廠污染物排放標準》(GB18918-2002)一級A排放標準;其中,化學需氧量(COD)、氨氮(NH3-N)及總磷(TP)指標將優於國家一級A標準。

濟南醫學中心項目一期的落實將有助完善濟南國際醫學科學中心區域內的污水處理設施,在未來更好滿足區內日益增長的水處理需求。此外,該項目的取得令光大水務在濟南市的設計水處理總規模突破1,500,000立方米/日,不僅增強了公司在當地的水處理服務能力,對於促進公司當地項目間的協同效應、鞏固當地市場地位也具有積極意義。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account